[Federal Register Volume 66, Number 178 (Thursday, September 13, 2001)]
[Notices]
[Pages 47674-47675]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-23011]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Office of the Secretary
White House Commission on Complementary and Alternative Medicine
Policy; Notice of Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is given of a meeting of the
White House Commission on Complementary and Alternative Medicine
Policy.
The purpose of this public meeting is to convene the Commission to
discuss possible Federal policy regarding complementary and alternative
medicine (CAM). The main focus of the meeting is the discussion of key
issues before the Commission and the development of draft
recommendations that may be included in the Final Report of the White
House Commission on Complementary and Alternative Medicine Policy.
Major issue areas to be considered by the Commission prior to
preparation of its Final Report include the following: Coordination of
CAM Research; Access to and Delivery of CAM Practices and Products;
Coverage and Reimbursement for CAM Practices and Products; Training and
Education of Health Care Practitioners in CAM; Development and
Dissemination of CAM Information for Health Care Providers and the
Public; CAM in Wellness, Self-Care, Health Promotion, and Disease
Prevention; Coordinating and Centralizing Private Sector and Federal
Sector CAM Efforts; and the Definition of CAM and Guiding Principles
for the preparation of the Final Report from the Commission. Comments
received at the meeting may be used by the Commission to prepare the
Report to the President as required by the Executive Order.
Opportunities for oral statements by the public will be provided on
October 5, from 5 p.m.-6 p.m. (Time approximate).
Name of Committee: The White House Commission on Complementary
and Alternative Medicine Policy.
Date: October 4-6, 2001.
Time: October 4--8 a.m.-6--p.m.; October 5--8 a.m.-6 p.m.;
October 6--8:30 a.m.-12:30 p.m.
Place: Neuroscience Office Building, National Institutes of
Health, Conference Rooms C-D, 6001 Executive Boulevard, Bethesda, MD
20892.
Contact Persons:Michele M. Chang, CMT, MPH, Executive Secretary;
OR Stephen C. Groft, Pharm.D., Executive Director, 6707 Democracy
Boulevard, Room 880, MSC-5467, Bethesda, MD 20892-5467, Phone: (301)
435-7592, Fax: (301) 480-1691, E-mail: [email protected].
Because of the need to obtain the views of the public on these
issues as soon as possible
[[Page 47675]]
and because of the early deadline for the report required of the
Commission, this notice is being provided at the earliest possible
time.
Supplementary Information: The White House Commission on
Complementary and Alternative Medicine Policy was established on
March 7, 2000 by Presidential Executive Order 13147. The mission of
the White House Commission on Complementary and Alternative Medicine
Policy is to provide a report, through the Secretary of the
Department of Health and Human Services, on legislative and
administrative recommendations for assuring that public policy
maximizes the benefits of complementary and alternative medicine to
Americans.
Public Participation
The meeting is open to the public with attendance limited to the
availability of space on a first come, first served basis. Members
of the public who wish to present oral comments may register by
faxing a request to register at 301-480-1691 or by accessing the
website of the Commission at http://whccamp.hhs.gov no later than
September 27, 2001.
Oral comments will be limited to five minutes, three minutes to
make a statement and two minutes to respond to questions from
Commission members. Due to time constraints, only one representative
from each organization will be allotted time for oral testimony. The
number of speakers and the time allotted may also be limited by the
number of registrants. Priority may be given to participants who
have not yet addressed the Commission at previous meetings. All
requests to register should include the name, address, telephone
number, and business or professional affiliation of the interested
party, and should indicate the area of interest or issue to be
addressed.
Any person attending the meeting who has not registered to speak
in advance of the meeting will be allowed to make a brief oral
statement during the time set aside for public comment if time
permits, and at the Chairperson's discretion. Individuals unable to
attend the meeting, or any interested parties, may send written
comments by mail, fax, or electronically to the staff office of the
Commission for inclusion in the public record.
When mailing or faxing written comments, please provide your
comments, if possible, as an electronic version on a diskette.
Persons needing special assistance, such as sign language
interpretation or other special accommodations, should contact the
Commission staff at the address or telephone number listed above no
later than September 27, 2001.
Dated: September 7, 2001.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 01-23011 Filed 9-12-01; 8:45 am]
BILLING CODE 4140-01-M